SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001278730-08-000010
Filing Date
2008-04-09
Accepted
2008-04-09 12:49:09
Documents
2
Period of Report
2008-03-17

Document Format Files

Seq Description Document Type Size
1 6K - STOCK OPTION GRANTS nrsop.htm 6-K 14131
2 nrsop002.gif GRAPHIC 684025
  Complete submission text file 0001278730-08-000010.txt   958107
Mailing Address 200 GRANVILLE STREET, SUITE 2760 VANCOUVER BC A1 V6C 1S4
Business Address 200 GRANVILLE STREET, SUITE 2760 VANCOUVER BC A1 V6C 1S4 604 696-3604
INNEXUS BIOTECHNOLOGY INC (Filer) CIK: 0001278730 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-50656 | Film No.: 08747134
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1